Search the Newsreel

Wasatch Advisors LP Decreases Stock Position in Esquire Financial Holdings, Inc. $ESQ

Wasatch Advisors LP reduced its stake in Esquire Financial Holdings, Inc. (NASDAQ:ESQ) by 15.1% in the second quarter, selling over 51,000 shares but still retaining a significant position worth $34.8 million. Despite this reduction, Esquire Financial shares have seen a 3.0% increase, nearing their …

Handelsbanken Fonder AB Sells 446,938 Shares of Bristol Myers Squibb Company $BMY

C-Link Squared Sets August Board Meeting to Review Interim Results and Dividend

Assenagon Asset Management S.A. Boosts Holdings in Bristol Myers Squibb Company $BMY

SEALSQ (LAES) Stock Looks Weak On Price But Rich On Sales

How Madison Square Garden Sports Corp. Class A (new) (MSGS) Affects Rotational Strategy Timing

This article analyzes Madison Square Garden Sports Corp. Class A (MSGS) stock using AI models to provide trading strategies. Key findings indicate a neutral near and mid-term outlook, with a potentially strong long-term positive bias. The analysis includes position trading, momentum breakout, and risk …

Madison Square Garden Sports Corp. Class A Actuals & Estimates (NYSE:MSGS)

This article provides an overview of Madison Square Garden Sports Corp. (MSGS) stock performance, financial actuals, and analyst estimates. It details the company's stock price, market capitalization, historical highs and lows, earnings, revenue, and employee count. The article also includes analysts' price targets and …

Pershing Square Holdings, Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026

Townsquare Media (TSQ) insiders file to sell 126,744 Class A shares

Townsquare Media Inc. (TSQ) has filed a notice of proposed sale for 126,744 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of approximately $711,133.39. These shares are related to previously vested restricted stock as compensation from various dates in …

AstraZeneca held talks with Bristol-Myers through spring, summer - FT

AstraZeneca reportedly engaged in discussions with Bristol-Myers Squibb over the spring and summer regarding a potential acquisition. The talks were centered around AstraZeneca purchasing Bristol-Myers in a mostly stock-based deal at a premium.

Csquare, Inc. (CSQR) Initiated with a Buy at Bank of America Securities

Bank of America Securities analyst Michael Funk initiated coverage on Csquare, Inc. (CSQR) with a Buy rating and a price target. RBC Capital also issued a Buy rating for CSQR, while J.P. Morgan initiated coverage with a Hold rating. These initiations reflect varied analyst …

Form 8K Z Squared Inc For: 11 August By Investing.com

This article announces that Z Squared Inc. filed a Form 8K on August 11. It provides a brief mention of the filing and includes the company's stock symbol and a slight negative price change. The content also lists various financial market data and popular …

Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors

Reports recently surfaced regarding a potential merger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb, causing significant industry speculation. Although a senior source reportedly debunked these rumors, the prospect of such a large-scale merger between two strong performers raised questions about its strategic rationale …

GameSquare Q2 2026 Earnings Call Transcript

GameSquare Holdings reported strong Q2 2026 results with revenue up 137% year-over-year to $18.5 million and adjusted EBITDA reaching a record $1.0 million. The company reiterated its full-year 2026 guidance, expecting $85-$90 million in revenue and over $5 million in adjusted EBITDA, driven by …

Jefferies initiates Csquare stock with buy rating on AI demand

Jefferies has initiated coverage on Csquare Inc (NYSE:CSQR) with a buy rating and a price target of $29.00, citing the company's enterprise-focused colocation platform, growth opportunities, and increasing enterprise AI demand. The firm believes investor concerns regarding leverage and Brookfield ownership have created an …

Pershing Square Holdings (PSH) Repurchases 30,054 Shares at $52.98 Average on August 10, 2026

News | Bristol Myers Squibb plans $2.3 billion Houston campus

Bristol Myers Squibb announced plans for a $2.3 billion, 600,000-square-foot campus in Houston's Generation Park, expected to create nearly 500 skilled jobs by 2030. This investment is part of a larger $40 billion commitment to U.S. operations, aiming to boost domestic manufacturing and reduce …

Is Schrödinger (SDGR) Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal?

Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston

Bristol Myers Squibb has announced a $2.3 billion investment to build a manufacturing campus in Houston, significantly increasing its initial estimate of $1 billion. The facility, expected to employ nearly 500 people and be completed by 2030, will produce small molecules, biologics, and antibody-drug …

BMS Chooses Houston for $2.3B Manufacturing Facility

Bristol Myers Squibb (BMS) has selected Houston as the location for a new $2.3 billion multi-modal manufacturing campus. This facility, part of BMS's $40 billion U.S. investment, will support the production of various treatments including small molecules, biologics, and ADCs. The campus aims to …

Pharma giant bets $2.3B on massive new Houston campus

Bristol Myers Squibb has chosen Houston for a new $2.3 billion manufacturing campus at Generation Park. This massive 600,000-square-foot facility is expected to create nearly 500 skilled jobs and approximately 2,000 indirect jobs during its construction phase. The investment is part of the company's …

New Bristol Myers Squibb facility coming to Generation Park

Global biopharmaceutical company Bristol Myers Squibb is set to establish a new pharmaceutical manufacturing campus in the Houston area, specifically near Generation Park. FOX 26's Karys Belger reported on this development. The facility will mark a significant expansion for the company in the region.

Bristol Myers Squibb to expand in Harris County

The article states that Bristol Myers Squibb plans to expand its operations in Harris County. No further details are provided regarding the nature or scope of this expansion.

BofA initiates Csquare stock with buy on data center growth

BofA Securities has initiated coverage on Csquare Inc (NYSE:CSQR) with a Buy rating and a price target of $46.00, suggesting a significant upside. The firm's investment thesis is based on the inability of data center supply to meet demand, Csquare's ability to quickly address …

Palmer Square Capital BDC Inc. (PSBD) CCO reports 1,854-share holding on Form 3

Palmer Square Capital BDC Inc.'s Chief Compliance Officer, Ben Wiesenfeld, has filed an initial statement of beneficial ownership (Form 3) reporting a direct holding of 1,854 shares of common stock. This filing indicates Wiesenfeld's initial stake in the company and does not reflect any …

Csquare (CSQR) grows H1 2026 revenue to $550.8M but loss widens on debt load

GameSquare FY26 Q2 net loss widens to $10.6 million; revenue more than doubled to $18.5 million

GameSquare reported a significant increase in revenue for Q2 2026, more than doubling to $18.5 million, while its GAAP net loss widened to $10.6 million. Despite the loss, gross margin improved to 49%, and non-GAAP adjusted EBITDA turned positive at $1 million. The company …

Csquare, Inc. Q2 2026: Revenue $280.4M, EPS $(0.47) — 10-Q Summary

Csquare, Inc. reported its second-quarter 2026 results, showing a 15% increase in revenue to $280.4 million compared to the previous year. However, the company's net loss widened significantly to $48.8 million, resulting in a diluted loss per share of $(0.47). Revenue growth was primarily …

BRISTOL-MYERS SQUIBB AKTIE: AI-Analysen, Prognose & Kursziel

Esquire Financial (ESQ) director exercises 20,000 options, uses 1,902 shares for costs

Esquire Financial Holdings, Inc. director Anthony Coelho exercised 20,000 stock options at $12.50 per share on August 7, 2026. For payment of the exercise price or tax liability, 1,902 shares were delivered or withheld at $131.38 per share. Following this transaction, Coelho holds 12,910 …

Oxford Square Capital Corp. (OXSQ) details Q2 2026 NAV and CLO-heavy portfolio

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

Bristol Myers Squibb is investing $2.3 billion to construct a new drug manufacturing campus in Houston, Texas, creating nearly 500 initial jobs and 2,000 construction jobs. The 600,000-square-foot facility at Generation Park will produce various next-generation medicines. Texas Governor Greg Abbott praised the investment, …

Esquire Financial Holdings Inc (ESQ) Stock News Today

This article provides current stock information for Esquire Financial Holdings Inc (ESQ), including its latest trading price, market capitalization, and P/E TTM ratio. It notes that more news is coming soon for ESQ, suggesting that this page serves as a hub for updates regarding …

Esquire Financial Holdings 2Q 2026: Revenue $41.3M, EPS $1.49— 10-Q Summary

Esquire Financial Holdings reported strong results for the second quarter ended June 30, 2026, with total interest income of $41.3M, net income of $13M, and diluted EPS of $1.49, all surpassing year-ago figures. This growth was driven by significant loan expansion in high-yield litigation …

Esquire Financial (Nasdaq: ESQ) boosts H1 2026 profit and closes $466M Signature deal

Bristol Myers Squibb to build $2.3 billion Houston campus

Bristol Myers Squibb announced Monday it will build a $2.3 billion drug manufacturing campus in Houston, Texas, part of the company's broader $40 billion commitment to invest in the United States over five years. The roughly 600,000-square-foot campus will be located at Generation Park, …